164 related articles for article (PubMed ID: 26869514)
21. H-Ferritin Is Preferentially Incorporated by Human Erythroid Cells through Transferrin Receptor 1 in a Threshold-Dependent Manner.
Sakamoto S; Kawabata H; Masuda T; Uchiyama T; Mizumoto C; Ohmori K; Koeffler HP; Kadowaki N; Takaori-Kondo A
PLoS One; 2015; 10(10):e0139915. PubMed ID: 26441243
[TBL] [Abstract][Full Text] [Related]
22. HBx modulates iron regulatory protein 1-mediated iron metabolism via reactive oxygen species.
Gu JM; Lim SO; Oh SJ; Yoon SM; Seong JK; Jung G
Virus Res; 2008 May; 133(2):167-77. PubMed ID: 18262302
[TBL] [Abstract][Full Text] [Related]
23. Ape1 regulates WNT/β-catenin signaling through its redox functional domain in pancreatic cancer cells.
Jiang S; Zhu L; Tang H; Zhang M; Chen Z; Fei J; Han B; Zou GM
Int J Oncol; 2015 Aug; 47(2):610-20. PubMed ID: 26081414
[TBL] [Abstract][Full Text] [Related]
24. Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer Agents.
Candelaria PV; Leoh LS; Penichet ML; Daniels-Wells TR
Front Immunol; 2021; 12():607692. PubMed ID: 33815364
[TBL] [Abstract][Full Text] [Related]
25. Extracellular matrix stimulates reactive oxygen species production and increases pancreatic cancer cell survival through 5-lipoxygenase and NADPH oxidase.
Edderkaoui M; Hong P; Vaquero EC; Lee JK; Fischer L; Friess H; Buchler MW; Lerch MM; Pandol SJ; Gukovskaya AS
Am J Physiol Gastrointest Liver Physiol; 2005 Dec; 289(6):G1137-47. PubMed ID: 16037546
[TBL] [Abstract][Full Text] [Related]
26. Identification of a novel peptide ligand of human transfrrin receptor 1 for targeted tumor delivery drug.
Xin Q; Cun Z; Xiaochang X; Meng L; Weina L; Qiang H; Yingqi Z; Zhen Y; Wei Z
Protein Pept Lett; 2013 Jan; 20(1):96-101. PubMed ID: 22670765
[TBL] [Abstract][Full Text] [Related]
27. Bcl-2 induces pro-oxidant state by engaging mitochondrial respiration in tumor cells.
Chen ZX; Pervaiz S
Cell Death Differ; 2007 Sep; 14(9):1617-27. PubMed ID: 17510660
[TBL] [Abstract][Full Text] [Related]
28. Reactive Oxygen Species and Targeted Therapy for Pancreatic Cancer.
Zhang L; Li J; Zong L; Chen X; Chen K; Jiang Z; Nan L; Li X; Li W; Shan T; Ma Q; Ma Z
Oxid Med Cell Longev; 2016; 2016():1616781. PubMed ID: 26881012
[TBL] [Abstract][Full Text] [Related]
29. Identification of Tumor Antigen AF20 as Glycosylated Transferrin Receptor 1 in Complex with Heat Shock Protein 90 and/or Transporting ATPase.
Shapiro JM; Chung W; Ogawa K; Barker L; Carlson R; Wands JR; Li J
PLoS One; 2016; 11(11):e0165227. PubMed ID: 27802297
[TBL] [Abstract][Full Text] [Related]
30. Iron metabolism protein transferrin receptor 1 involves in cervical cancer progression by affecting gene expression and alternative splicing in HeLa cells.
Huang N; Wei Y; Cheng Y; Wang X; Wang Q; Chen D; Li W
Genes Genomics; 2022 Jun; 44(6):637-650. PubMed ID: 35066810
[TBL] [Abstract][Full Text] [Related]
31. Effects of cell proliferation on the uptake of transferrin-bound iron by human hepatoma cells.
Lee AW; Oates PS; Trinder D
Hepatology; 2003 Oct; 38(4):967-77. PubMed ID: 14512884
[TBL] [Abstract][Full Text] [Related]
32. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.
Ralph SJ; Rodríguez-Enríquez S; Neuzil J; Saavedra E; Moreno-Sánchez R
Mol Aspects Med; 2010 Apr; 31(2):145-70. PubMed ID: 20206201
[TBL] [Abstract][Full Text] [Related]
33. Ether phospholipids are required for mitochondrial reactive oxygen species homeostasis.
Chen Z; Ho IL; Soeung M; Yen EY; Liu J; Yan L; Rose JL; Srinivasan S; Jiang S; Edward Chang Q; Feng N; Gay JP; Wang Q; Wang J; Lorenzi PL; Veillon LJ; Wei B; Weinstein JN; Deem AK; Gao S; Genovese G; Viale A; Yao W; Lyssiotis CA; Marszalek JR; Draetta GF; Ying H
Nat Commun; 2023 Apr; 14(1):2194. PubMed ID: 37069167
[TBL] [Abstract][Full Text] [Related]
34. Gallium Maltolate Disrupts Tumor Iron Metabolism and Retards the Growth of Glioblastoma by Inhibiting Mitochondrial Function and Ribonucleotide Reductase.
Chitambar CR; Al-Gizawiy MM; Alhajala HS; Pechman KR; Wereley JP; Wujek R; Clark PA; Kuo JS; Antholine WE; Schmainda KM
Mol Cancer Ther; 2018 Jun; 17(6):1240-1250. PubMed ID: 29592883
[TBL] [Abstract][Full Text] [Related]
35. Ribosomal protein L10 in mitochondria serves as a regulator for ROS level in pancreatic cancer cells.
Yang J; Chen Z; Liu N; Chen Y
Redox Biol; 2018 Oct; 19():158-165. PubMed ID: 30172100
[TBL] [Abstract][Full Text] [Related]
36. Metabolic capacity regulates iron homeostasis in endothelial cells.
Carraway MS; Suliman HB; Madden MC; Piantadosi CA; Ghio AJ
Free Radic Biol Med; 2006 Dec; 41(11):1662-9. PubMed ID: 17145554
[TBL] [Abstract][Full Text] [Related]
37. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
Martinez-Outschoorn U; Sotgia F; Lisanti MP
Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
[TBL] [Abstract][Full Text] [Related]
38. Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer.
Kato S; Kubota K; Shimamura T; Shinohara Y; Kobayashi N; Watanabe S; Yoneda M; Inamori M; Nakamura F; Ishiguro H; Nakaigawa N; Nagashima Y; Taguri M; Kubota Y; Goshima Y; Morita S; Endo I; Maeda S; Nakajima A; Nakagama H
Cancer Sci; 2011 Nov; 102(11):2029-37. PubMed ID: 21812859
[TBL] [Abstract][Full Text] [Related]
39. A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency.
Jabara HH; Boyden SE; Chou J; Ramesh N; Massaad MJ; Benson H; Bainter W; Fraulino D; Rahimov F; Sieff C; Liu ZJ; Alshemmari SH; Al-Ramadi BK; Al-Dhekri H; Arnaout R; Abu-Shukair M; Vatsayan A; Silver E; Ahuja S; Davies EG; Sola-Visner M; Ohsumi TK; Andrews NC; Notarangelo LD; Fleming MD; Al-Herz W; Kunkel LM; Geha RS
Nat Genet; 2016 Jan; 48(1):74-8. PubMed ID: 26642240
[TBL] [Abstract][Full Text] [Related]
40. Design and Synthesis of Novel Reactive Oxygen Species Inducers for the Treatment of Pancreatic Ductal Adenocarcinoma.
Kuang Y; Sechi M; Nurra S; Ljungman M; Neamati N
J Med Chem; 2018 Feb; 61(4):1576-1594. PubMed ID: 29328656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]